Total Assets
account_balance1.5B USD
No comparison
RAREUltragenyx Pharmaceutical Inc.$ --
Ultragenyx Pharmaceutical Inc.
RARE
$ -
-
You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.
account_balanceBalance Sheet (BS) Summary
Shareholders' Equity
savings-80M USD
No comparison
Equity Ratio
pie_chart-5.2%
No comparison
Book Value Per Share
paid-0.81USD
No comparison
Asset & Liability Mix
Non-current AssetsCurrent AssetsEquityOtherNon-current LiabilitiesCurrent Liabilities
Equity Ratio Trend (5 Years)
Unit: %
21.510.50
2021
2022
2023
2024
2025
Balance Sheet Details
Item
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
Unlock Long-Term Balance Sheet Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.